According to these findings, the combined inhibition of Hsp90 and Hspa9 was found to dramatically reduce tumor growth in a liver cancer xenograft model, and the Hsp90 inhibitor was also found to promote the expression of Hspa9 [32]. This evidence concerns the gene HSP90AA1 and liver cancer.